United States News Todas as matérias

Biohaven (NYSE:BHVN) will present updated Phase 1 data for BHV-1530 at the EORTC-NCI-AACR oncology symposium in November 2026, covering the ongoing BHV1530-101 study.

Ramaco Resources (NASDAQ:METC) secured a $30 million court judgment for its subsidiary Ramaco Resources in an insurance coverage dispute against Chubb subsidiaries Federal Insurance Company and ACE American Insurance Company.

Palatin Technologies (NASDAQ:PTN) reported fiscal 2026 collaboration and license revenue of $13.2 million, compared with zero revenue in fiscal 2025.

Kandi Technologies (NASDAQ:KNDI) secured a second heavy-truck battery swap station equipment order through its China Battery Exchange subsidiary from QIJI Energy, a subsidiary of CATL.

AN2 Therapeutics (NASDAQ:ANTX) received an extension of funding from the Gates Foundation to support its tuberculosis research collaboration with GSK focused on boron-based leucyl-tRNA synthetase inhibitors.

Eton Pharmaceuticals (NASDAQ:ETON) launched IMPAVIDO (miltefosine) capsules in the United States under exclusive U.S. commercialization rights for the treatment of certain forms of leishmaniasis.

Armlogi Holding (NASDAQ:BTOC) reported fiscal 2026 revenue of $185.8 million for the year ended June 30, 2026, compared with $190.4 million in fiscal 2025.

Brixmor Property Group (NYSE:BRX) and Everview Partners agreed to acquire Slate Grocery REIT in a $2.34 billion transaction involving 115 grocery-anchored centers.

Pfizer (NYSE:PFE) announced it will present data from 45 oncology research abstracts at the European Society for Medical Oncology Congress 2026, taking place October 23–27 in Madrid, Spain.

Eli Lilly (NYSE:LLY) launched the Change the Course Commitment, an initiative aimed at increasing access to its diabetes and obesity medicines in resource-limited settings before 2040.

Kodiak Sciences (NASDAQ:KOD) reported that Zenkuda and tabirafusp-ted met primary vision endpoints in the Phase 3 DAYBREAK trial evaluating treatments for wet age-related macular degeneration.

Codexis (NASDAQ:CDXS) signed an agreement with an unnamed siRNA drug developer to explore stereo-defined fragment synthesis using its ECO Synthesis platform.

National Healthcare Properties (NYSE:NHP) agreed to sell 40 outpatient medical facilities for approximately $531 million, with closing expected in the fourth quarter of 2026.

MediciNova (NASDAQ:MNOV) reported topline results from a Phase 2 placebo-controlled trial evaluating MN-001, also known as tipelukast, in patients with type 2 diabetes, fatty liver disease, and elevated triglycerides.

Gray Media (NYSE:GTN) raised its third-quarter 2026 political advertising revenue guidance to $188 million–$195 million, compared with its previous forecast of $165 million–$185 million.

Zymeworks (NASDAQ:ZYME) completed its acquisition of Theravance Biopharma for $17 per share, adding rights to YUPELRI profit sharing and international royalties.

Hudbay Minerals (NYSE:HBM) extended the reserve mine life of its Snow Lake operations in Manitoba to 2043 under an updated plan that increases projected gold production.

IDEAYA Biosciences (NASDAQ:IDYA) promoted Dr. Michael White from chief scientific officer to president of research and development, effective September 28, 2026.

U.S.-listed gold miners fell in premarket trading as spot gold prices declined 3.2% to $4,149.89 per ounce, reaching their lowest level since August 5.

NVIDIA (NASDAQ:NVDA) introduced its Open Agent Safety Platform, an open-source framework designed to provide controls for AI agents through runtime monitoring and policy enforcement tools.

Amprius Technologies (NYSE:AMPX) received a grant of up to $75 million from the U.S. Department of War to retrofit an existing domestic production line for high-energy-density batteries used in unmanned aerial systems.

Brent crude oil prices rose 2.49% on Monday after U.S. President Donald Trump rejected a peace proposal from Iran aimed at resolving their conflict and reopening the Strait of Hormuz.

Webuy Global (NASDAQ:WBUY) reported first-half 2026 revenue from continuing operations of US$14.31 million following its exit from the Singapore grocery business.

NIO (NYSE:NIO) signed definitive agreements with subsidiaries of Geely Holding Group covering investments and asset transactions involving NIO Power’s battery swapping and charging businesses.